Congruent with our current results, the therapeutic effect of anti-PD-1 and anti-CTLA4 was conditional on a CD4-driven anti-tumor response, while depletion of CD4+ cells still had a less pronounced effect on overall survival than depletion of CD8+ cells. This evidence concerns the gene CD8A and neoplasm.